Phospholipases A 2 (PLA 2 s) form a family of enzymes catalyzing the hydrolysis of membrane phospholipids into arachidonic acid, which is the major precursor of pro-inflammatory eicosanoids. As a result, PLA 2 s have been considered as potential targets in anti-inflammatory drug discovery.
Marine natural products targeting phospholipases A2
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Introduction
Inflammation is the response of vascular tissues to harmful stimuli such as injury, pathogens, or irritants. While inflammation normally functions as a defense mechanism in higher animals, deregulated inflammation is implicated in a large number of diseases such as autoimmune diseases, allergies, asthma, rheumatoid arthritis, inflammatory bowel diseases, pelvic inflammatory diseases, glomerulonephritis, atherosclerosis, myocardial ischemia, and cancer [1] [2] [3] . The process of inflammation is controlled by a group of substances called chemical mediators [1] . Endogenous chemical mediators consist of vasoactive amines, cytokines, bradikinin, fibrin, complement components, eicosanoids, platelet activating factor (PAF), nitric oxide (NO), and neuropeptides [1] . Eicosanoids, in particular, play a critical role in virtually every step of inflammation. Eicosanoids, which comprise prostaglandins, prostacyclins, thromboxanes, and leukotrienes, are a family of oxygenated fatty acid metabolized by cyclooxygenases (COX) and lipoxygenases (LOX) from arachidonic acid [1] . Despite the extensive efforts invested in developing drugs that suppress the conversion of arachidonic acid into pro-inflammatory eicosanoids, the latter approach has been unsuccessful. Undesired side-effects resulting from the lack of specificity of COX and LOX are responsible for the failure of the concept [2] . As an alternative, the quest for inhibitors of phospholipases A 2 (PLA 2 s), the enzymes that catalyze the hydrolysis of membrane phospholipids into arachidonic acid, has opened up a new research avenue in anti-inflammatory drug discovery [2, [4] [5] [6] . As a matter of fact, PLA 2 s isolated from snake venom have been shown to induce all the inflammatory symptoms of snakebite such as acute pain, oedema, hypotension, hemorrhage, and neuromuscular junction blockage.
Furthermore, rheumatoid arthritis, asthma, psoriasis, myocardial ischemia, and pancreatis have all been shown to be associated with elevated levels of serum PLA 2 .
Lysophospholipids produced by PLA 2 s have also been shown to induce gastric ulceration in rats, and to induce an inflammation similar to acute cholecystitis in the gall bladder mucosa [3] . Here, we review the properties of marine PLA 2 inhibitors identified since the first discovery of PLA 2 inhibitory activity in the marine natural product manoalide (1), by research groups lead by Edward Dennis [4] and by Robert Jacobs [5] at the universities of San Diego and Santa Barbara, respectively, in the mid 1980's.
-4 - -5 -cPLA 2 s. The latter two are present in most types of cells, and both of them are known to be implicated in inflammation through eicosanoid biosynthesis [6, [9] [10] [11] .
As illustrated in Figure 1 , PLA 2 s initiate the pro-inflammatory signaling cascade by catalyzing the hydrolysis of the sn-2 acyl ester bond of membrane phospholipids, leading to the release of the -6 fatty acid arachidonic acid and of lysophospholipids [7] . Next, arachidonic acid is oxygenated into prostaglandin (PG) PGH 2 by COX, or into 5-hydroperoxyeicosatetraenoic acid (5-HPTETE) by LOX. -6 -lysophospholipids induce the activation and extravasion of pro-inflammatory leukocytes and activate the secretion of pro-inflammatory histamine by mast cells [7] .
Marine PLA 2 inhibitors
PLA 2 activity has been reported in several marine organisms, including hard and soft corals, jellyfish, starfish, sea anemones, and soft corals, and marine snails [11, 12] . Hence, from an ecological perspective, it is not surprising that marine organisms have developed potent PLA 2 inhibitors, which may be used as chemical defences in their natural environment. Marine PLA 2 inhibitors reported to date are primarily terpenoids isolated from sponges, nudibranchs, and algae. Their chemical and biological properties are described below and summarized in Table 1 
PLA 2 inhibiting sesquiterpenes
One of the most investigated marine PLA 2 inhibitors is the merosesquiterpene bolinaquinone (1) isolated from the sponge Dysidea sp. Bolinaquinone (1) has been
shown to inhibit the enzymatic activity of sPLA 2 with an IC 50 value of 100 nM [13] .
While the inhibition of sPLA 2 by bolinaquinone (1) is very potent, it is not selective against this enzyme. Bolinaquinone 1 is known to also affects cPLA 2 [13] [14] [15] [16] [17] [18] [19] .
Bolinaquinone (1) is known to reduce LTB 4 production in neutrophils and NO and PGE 2 production in macrophages [13] [14] [15] [16] [17] [18] [19] . Another, closely related sesquiterpenoid quinone, ilimaquinone (2) isolated from the sponge Hippiospongia metachromia [20] , has also been shown to inhibit PLA 2 (IC 75 = 270 M against bee venom sPLA 2 ) [19] .
The anti-psoriasis sesquiterpene hydroquinone avarol (3) and the sesquiterpene quinones avarone (4) and dysidine (5) isolated from the sponge Dysidea avara inhibit sPLA 2 activity and PGE 2 release in keratinocytes and in monocytes (IC 50 = 2 M).
Furthermore, avarol has been shown to reduce eicosanoid release and ROS generation in stimulated leukocytes [17] [18] [19] . Dysidiotronic acid (6) isolated from Dysidea sp.
also inhibits sPLA 2 (IC 50 = 2.6 M) [18, 19] . The sesquiterpene lactone cavernolide 
PLA 2 inhibiting diterpenes
The diterpenes gracilin A (10), aplyroseol 1 (11), and 12-acetoxytetrahydroaplysulphurin 1 (12) isolated from Aplysilla sp. sponges [22] , and dendrillolide A (13) and norrisolide (14) isolated from the sponge Dendrilla sp.
inhibit bee venom sPLA 2 with IC 50 values around 5 M [20] . They all contain a masked 1,4-dialdehyde function, which has been suggested to play a key role in their bioactivity [20] . The meroditerpne epitaondiol (15) 
PLA 2 inhibiting sesterterpenes
Sesterterpenes have an outstanding potential as anti-inflammatory compounds.
The sesterterpene manoalide (20) , which was isolated for the first time in the early 1980s from the sponge Luffariella variabilis by Scheuer et al. [26] , became the first marine natural product reported as PLA 2 inhibitor, and it remains, to date, the most investigated marine PLA 2 antagonist. The PLA 2 inhibiting properties of manoalide (20) were discovered simultaneously by research groups lead by Edward Dennis [4] and by Robert Jacobs [5] [20] . Manoalide analogues have also been isolated from nudibranchs of the Chromodoris genus, which prey primarily on Luffariella sp. sponges [29] .
Noteworthy, the nudibranch derived compounds, which include luffariellins C (26) and D (27) , and deoxymanoalide (28) does bind covalently to bee venom PLA 2 , the key step in the PLA 2 inhibitory activity of scalaradial (35) is, as observed with petrosaspongiolide M (34), its nonvalent binding to the enzyme's active site [33] . The furanosesterterpene palinurin (37) isolated from the sponge Ircinia echinata has been shown to inhibit TXB 2 (IC 50 = 5 M), and the furan ring is thought to be the pharmacophore of the molecule [36] . 
Interestingly, studies on diastereoisomers of cladocoran A (40) and B (41) revealed
that the presence of a -hydroxybutenolide moiety itself is not sufficient for PLA 2 inhibitory activity, and that the size and shape of the molecule also play critical roles towards the compounds' potency [37] .
Non-terpenoid marine PLA 2 inhibitors
The bromohydroquinones cymopol (42) and cyclocymopol (43) isolated from the green alga Cymopolia barbata inhibit bee venom sPLA 2 
Future perspectives and concluding remarks
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Specific PLA 2 inhibitors are indeed more likely to be bioactive at lower concentrations than non-specific inhibitors, and they are less prone to induce undesired side-effects [8] . Amongst the marine natural products included in the present review article, bolinaquinone (1) and manoalide (20) and its analogues have been shown to potently inhibit PLA 2 s, but in a non-specific manner. Manoalide (20) has been valued as a potential drug candidate, and it has been taken forward to clinical trials, but it had to be dropped due to formulation problems. To our knowledge, the sesterterpenes palauolol (38) and palauolide (39) have only been A c c e p t e d M a n u s c r i p t   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -11 -evaluated for their potential to inhibit bee venom sPLA 2 . Yet, their IC 50 values were rather promising, and if the compounds' bioactivity could be shown to be paralleled with a good level of specificity, then 38 and 39 could potentially be considered as promising drug candidates, based on their PLA 2 inhibiting properties. Finally, when considering PLA 2 -inhibiting compounds to be taken forward into more advanced studies, it is important to make sure that the compounds in question do not completely abolish the PLA 2 activity. Instead, they should only bring PLA 2 activity down to the basal level, as some vital cellular housekeeping depends on basal levels of PLA 2 activity.
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